Xbrane And Biogen Ally On Certolizumab Pegol Biosimilar
Xbrane CEO Martin Åmark Highlights Potential For Xcimzane Rival To Cimzia
• By David Wallace
Xbrane has secured Biogen as a partner on its Xcimzane certolizumab pegol biosimilar • Source: molekuul.be / Alamy Stock Photo 
